Metraipolis › archive › dc_4d1059ae33fa

Class-Specific Effects of ARBs Versus ACE Inhibitors on Survival and Cardiovascular Outcomes in MASLD — Europe PMC PMID:41155354

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41155354
DOI
10.3390/ijms262010061
License (as archived)
solo-consultazione
Archived
2026-11-09T06:23:57.253Z
SHA-256 of the archived text
2b0745cf12ed92eca2a46b5a069f5610ee4666300e206dc5d0281aa8cc491516
Stable URL of this page
https://metraipolis.com/documento/dc_4d1059ae33fa

How to cite

Class-Specific Effects of ARBs Versus ACE Inhibitors on Survival and Cardiovascular Outcomes in MASLD — Europe PMC PMID:41155354 — Europe PMC (en), https://europepmc.org/article/MED/41155354 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4d1059ae33fa (Metraipolis archive dc_4d1059ae33fa, sha256 2b0745cf12ed92eca2a46b5a069f5610ee4666300e206dc5d0281aa8cc491516)
BibTeX
@misc{dc4d1059ae33fa,
  title = {Class-Specific Effects of ARBs Versus ACE Inhibitors on Survival and Cardiovascular Outcomes in MASLD — Europe PMC PMID:41155354},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41155354},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4d1059ae33fa; sha256 2b0745cf12ed92eca2a46b5a069f5610ee4666300e206dc5d0281aa8cc491516},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41155354. Agents can read the archived copy with the MCP tool read_document.